The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

“The de-extinction of the dire wolf and an end-to-end system for de-extinction is transformative and heralds an entirely new ...

A biotechnology company called Colossal Biosciences claims to have resurrected the dire wolf, a species that went extinct ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...

REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek ...

I believe that a good speculative biotech to go over for the "Exclusive ... but not as much as those who do smoke [In other words, it's rare for patients who don't smoke to get it, but can still ...

Joshua Oduyemi, the Nigerian-American entrepreneur behind Sheatrust Capital, Multicent, and Abbegen, is redefining venture ...

Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and ...

Brown University set to have $510M in federal research grants frozen: reports Northwestern has also not received official word of the funding ... university told Fierce Biotech in an email.

Cynical shareholders who have watched the stock zigzag up and down as shown above might question whether stabilization is the correct word. I submit that business stabilization differs from share ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Improving negotiators’ skills starts in the training room, but changing the negotiator’s mindset takes engagement and ...